Expert consensus on the treatment of rheumatoid arthritis with chinese patent medicines

Journal of Alternative and Complementary Medicine

Volumn 19, Issue 2, 2013, Pages 111-118

  Zhao, Jing ^a   Zha, Qinglin ^b   Jiang, Miao ^a   Cao, Hongxin ^a   Lu, Aiping ^a  

^a INSTITUTE OF CHINESE MATERIA MEDICA   (China)

^b JIANGXI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DUHUO JISHENG; HERBACEOUS AGENT; LEIGONGTENG DUOGAN; SIMIAO; TOTAL GLUCOSIDE OF PAEONIA; UNCLASSIFIED DRUG; WANGBI; YISHEN JUANBI; ZHENGQING DENGTONGNING;

ABSENCE OF SIDE EFFECTS; ADULT; AMENORRHEA; ARTICLE; CHINESE HERB; CHINESE MEDICINE; CHINESE PATENT MEDICINE; CONSENSUS DEVELOPMENT; DELPHI STUDY; DIARRHEA; DRUG ERUPTION; DYSMENORRHEA; GONADAL DYSGENESIS; HUMAN; NAUSEA; PATENT; PRIORITY JOURNAL; QUESTIONNAIRE; RHEUMATOID ARTHRITIS; STOMACH DISCOMFORT; STOMACH PAIN; THROMBOCYTOPENIA; TREATMENT INDICATION; VOMITING;

ADULT; ARTHRITIS, RHEUMATOID; CONSENSUS; DELPHI TECHNIQUE; DIAGNOSIS, DIFFERENTIAL; DRUG INTERACTIONS; DRUGS, CHINESE HERBAL; HUMANS; INTEGRATIVE MEDICINE; MEDICINE, CHINESE TRADITIONAL; MIDDLE AGED; PHYTOTHERAPY; PRACTICE GUIDELINES AS TOPIC; QUESTIONNAIRES; RHEUMATOLOGY;

EID: 84874074343     PISSN: 10755535     EISSN: 15577708     Source Type: Journal    
DOI: 10.1089/acm.2011.0370     Document Type: Article

References (37)

1. Aletaha D, Neogi T, Silman AJ, et al. Rheumatism collaborative initiative Rheumatology/European League Against an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 2010;69:1580-1588
2. Pieringer H, Pichler M. Cardiovascular morbidity and mortality in patients with rheumatoid arthritis: Vascular alterations and possible clinical implications. QJM 2011;104:13-26
3. Visser K, van der Heijde D. Optimal dosage and route of administration of methotrexate in rheumatoid arthritis: A systematic review of the literature. Ann Rheum Dis 2009;68:1094-1099
4. Doan T, Massarotti E. Rheumatoid arthritis: An overview of new and emerging therapies. J Clin Pharmacol 2005;45:751-762
5. Edwards MH, Leak AM. Pericardial effusions on anti-TNF therapy for rheumatoid arthritis: A drug side effect or uncontrolled systemic disease? Rheumatology (Oxford) 2009;48:316-317
6. Karaca-Mandic P, Joyce GF, Goldman DP, Laouri M. Cost sharing, family health care burden, and the use of specialty drugs for rheumatoid arthritis. Health Serv Res 2010;45: 1227-1250
7. Zhang BS, Dong JH, Zhou ZY. Internal Medicine of TCM. 1st rev. Shanghai: Scientific and Technical Publishers, 1985: 263P
8. Wang JF, Cai CZ, Kong CY, et al. A computer method for validating traditional Chinese medicine herbal prescriptions. Am J Chin Med 2005;33:281-297
9. Wu YH, Liu W. A review of experimental researches in Chinese traditional patent medicines for rheumatoid arthritis. China J Trad Chin Med Pharmacy 2010;25:1846-1849
10. Wu MB, Shen Y, Long Y. Clinical research progress of rheumatoid arthritis treatment using Chinese formulated products. Chin Arch TCM 2008;26:1974-1976
11. Xu M, Liu L, Qi C, et al. Sinomenine versus NSAIDs for the treatment of rheumatoid arthritis: A systematic review and meta-analysis. Planta Med 2008;74:1423-1429
12. Goldbach-Mansky R, Wilson M, Fleischmann R, et al. Comparison of Tripterygium wilfordii Hook F versus sulfasalazine in the treatment of rheumatoid arthritis: A randomized trial. Ann Intern Med 2009;151:229-240
13. Chen KJ, Lu AP. Situation of integrative medicine in China: Results from a national survey in 2004. Chin J Integr Med 2006;12:161-165
14. He Y, Lu A, Zha Y, et al. Correlations between symptoms and ACR20 efficacy in 396 cases of rheumatoid arthritis. J Clin Rheumatol 2007;13:317-321
15. Ferraccioli G, Salaffi F, Nervetti A, et al. Slow-acting drugs outcome is no different than 15 years ago. J Rheumatol 1990;17:1249-1250
16. He Y, Lu A, Zha Y, et al. Differential effect on symptoms treated with traditional Chinese medicine and western combination therapy in RA patients. Complement Ther Med 2008;16:206-211
17. Minas H, Jorm AF. Where there is no evidence: Use of expert consensus methods to fill the evidence gap in low-income countries and cultural minorities. Int J Ment Health Syst 2010;21;4:33
18. Myers H, Thomas E, Dziedzic K. What are the important components of the clinical assessment of hand problems in older adults in primary care? Results of a Delphi study. BMC Musculoskelet Disord 2010;11:178
19. Jones J, Hunter D. Consensus methods for medical and health services research. BMC 1995;311:376-380
20. Lu C, Zha Q, Chang A, et al. Pattern differentiation in Traditional Chinese Medicine can help define specific indications for biomedical therapy in the treatment of rheumatoid arthritis. J Altern Complement Med 2009;15:1021-1025
21. Qiu D, Kao PN. Immunosuppressive and anti-inflammatory mechanisms of triptolide, the principal active diterpenoid from the Chinese medicinal herb Tripterygium wilfordii Hook. f. Drugs R D 2003;4:1-18
22. Tao X, Lipsky PE. The Chinese anti-inflammatory and immunosuppressive herbal remedy Tripterygium wilfordii Hook F. Rheum Dis Clin North Am 2000;26:29-50
23. Chen K J, Chen K. Achievements in clinical research of treating internal diseases with traditional Chinese medicine in recent years. Chin Med J (Engl) 1989;102:735-739
24. Gao ZG, Zang AC, Bai RX. Radix Tripterygium Wilfordii Hook F in rheumatoid arthritis, ankylosing spondylitis and juvenile rheumatoid arthritis. Chin Med J (Engl) 1986;99: 317-320
25. Okuda T, Umezawa Y, Ichikawa M, et al. A case of drug eruption caused by the crude drug Boi (Sinomenium stem/ Sinomeni caulis et Rhizoma). J Dermatol 1995;22:795-800
26. Liu W, Liu XY, Liu B. Clinical observation on treatment of rheumatoid arthritis with zhengqing fengtongning retard tablets: A report of 60 cases. Zhong Xi Yi Jie He Xue Bao 2006; 4:201-202
27. The pharmacokinetics and tissue distribution of sinomenine in rats and its protein binding ability in vitro. Life Sci 2005; 77:3197-3209
28. Ou Y, Li W, Li X, et al. Sinomenine reduces invasion and migration ability in fibroblast-like synoviocytes cells cocultured with activated human monocytic THP-1 cells by inhibiting the expression of MMP-2, MMP-9, CD147. Rheumatol Int 2011;31:1479-1485
29. Zhang L, Zhang G. Clinical observation study on treatment of rheumatoid arthritis with modified Simiao pill: A report of 92 cases. Hebei J TCM 2002;24:917-918
30. Yang XL, Song XL. Clinical observation on treatment of rheumatoid arthritis with DHJS prescription: A report of 68 cases. Shanxi J TCM 2010;31:439-440
31. Li W. Clinical observation on treatment of rheumatoid arthritis with DHJS prescription: A report of 58 cases. J Liaoning Med University 2009;30:240
32. Perera PK, Peng C, Lu X, et al. Effects of Yishen Juanbi (YJB) pill on experimental rheumatoid arthritis. Chin J Nat Med 2010;8:0057-0061
33. Li S, Hu X, Jing Z. Therapeutic effect of Yi Shen Juan Bi pill on rheumatoid arthritis. Zhejiang J Clin Med 2008;10:628-629
34. Yang M, Ji HW, Cao XJ, et al. Clinical study of Wangbi pills in the treatment of rheumatoid arthritis (yin deficiency in liver and kidney, blood stasis stagnation syndrome). Mod Trad Chin Med 2009;29:21-23
35. Zheng YQ, Wei W. Total glucosides of paeony suppresses adjuvant arthritis in rats and intervenes cytokine-signaling between different types of synoviocytes. Int Immunopharmacology 2005;5:1560-1573
36. Chang Y,WeiW, Zhang L, Xu HM.Effects and mechanisms of total glucosides of paeony on synoviocytes activities in rat collagen-induced arthritis. J Ethnopharmacol 2009;121:43-48
37. Wang Y, Xing HY. Clinical observation on effect of total glucosides of paeony combined with methotrexate on rheumatoid arthritis. Zhongguo Zhong Xi Yi Jie He Za Zhi 2007;27:839-840